运用PDCA循环管理预防化疗药物所致静脉炎临床探讨

Clinical Study of the Application of PDCA Circular Administration in Preventing the Occurrence of Phlebitis Caused by Chemotherapeutic Drugs

目的探讨PDCA循环管理预防化疗药物所致静脉炎的发生中的运用,降低化疗药物所致静脉炎的发生率,减轻患者的痛苦,提高患者对护理工作的满意度。方法将100例化疗患者随机分为循环管理护理组(PDCA组)和常规化疗护理组(常规组);PDCA组从化疗前1天至该化疗周期结束后7天采用循环管理。结果PDCA组静脉炎的发生率比常规组低(P<0.05),两组静脉炎发生率差异有统计学意义。结论运用PDCA循环管理能有效地预防化疗所致静脉炎的发生,起到减轻患者痛苦、提高患者生存质量及护理质量的作用。

Objective To discuss the application of PDCA circular administration in preventing the occurrence of phlebitis caused by chemotherapeutic drugs. Methods 100 eases of chemotherapy were randomly divided into 2 groups ： PDCA group and routine group; from 1 day before ehemotherapy to 7 days after chemotherapy ended, circular administration was performed in PDCA group. Results The occurrence of phlebitis in PDCA group was much lower than that in routine group （ P 〈 0.05 ）, the differenee of phlebitis occurrence between the 2 groups was of statistical significance. Conclusions The application of PDCA circular administration can effectively prevent the occurrence of phlebitis, decrease the pain of the patients and raise the quality of life and the nursing.